171 related articles for article (PubMed ID: 36538293)
21. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
Petersen MP; Möller S; Bygum A; Voss A; Bliddal M
Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
Perlemuter G; Cacoub P; Sbaï A; Hausfater P; Thibault V; Le TH; Wechsler B; Buffet C; Piette JC
J Rheumatol; 2003 Jul; 30(7):1473-8. PubMed ID: 12858443
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus.
Ahmed MM; Berney SM; Wolf RE; Hearth-Holmes M; Hayat S; Mubashir E; Vanderheyde H; Chang WL; King JW
Am J Med Sci; 2006 May; 331(5):252-6. PubMed ID: 16702794
[TBL] [Abstract][Full Text] [Related]
24. [Prevalence of hepatitis C in patients with systemic lupus erythematosus in the Hospital of Federal University of Rio de Janeiro (HUCCF)].
Costa Cde A; Papi JA; Coelho HS; Nogueira C; Vanderboght B; Soares JA
Rev Assoc Med Bras (1992); 2002; 48(1):42-7. PubMed ID: 12185635
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist.
Stull C; Sprow G; Werth VP
J Rheumatol; 2023 Jan; 50(1):27-35. PubMed ID: 36109075
[TBL] [Abstract][Full Text] [Related]
26. Association between oral lesions and disease activity in lupus erythematosus.
Del Barrio-Díaz P; Reyes-Vivanco C; Cifuentes-Mutinelli M; Manríquez J; Vera-Kellet C
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):349-356. PubMed ID: 31566809
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features.
Wallace DJ; Pistiner M; Nessim S; Metzger AL; Klinenberg JR
Semin Arthritis Rheum; 1992 Feb; 21(4):221-6. PubMed ID: 1570517
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
[TBL] [Abstract][Full Text] [Related]
30. Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus.
Szepietowski JC; Nilganuwong S; Wozniacka A; Kuhn A; Nyberg F; van Vollenhoven RF; Bengtsson AA; Reich A; de Vries DE; van Hartingsveldt B; Robinson DW; Gordon R; Hsu B
Arthritis Rheum; 2013 Oct; 65(10):2661-71. PubMed ID: 23896980
[TBL] [Abstract][Full Text] [Related]
31. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study.
Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G
Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients.
Chen X; Hong L; Zhang W; Yuan M; Yang Q; Mao H; Chen W; Yu X
Med Sci Monit; 2015 Jul; 21():1955-9. PubMed ID: 26148056
[TBL] [Abstract][Full Text] [Related]
36. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
37. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
Cho YM; Furie R
Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
Wang S; Chen Y; Xu X; Hu W; Shen H; Chen J
Oncotarget; 2017 Nov; 8(60):102437-102445. PubMed ID: 29254259
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
